Showing results (1411-1420 of 1,484) with videos related to

Sort By:
Pageof 149
Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.
British Journal of Haematology|May 30, 2018
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMTDonal P McLornan, Richard Szydlo, Marie Robin, et al.
Journal of Medicinal Chemistry|March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV proteaseF E Boyer, J V Vara Prasad, J M Domagala, et al.
Journal of Molecular and Cellular Cardiology|December 8, 2024
Patient-specific hiPSC-derived cardiomyocytes indicate allelic and contractile imbalance as pathogenic factor in early-stage Hypertrophic CardiomyopathyNatalie Weber, Judith Montag, Kathrin Kowalski, et al.
Klinische Padiatrie|July 24, 2012
Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcomaU Thiel, P Wolf, A Wawer, et al.
Journal of Medicinal Chemistry|August 30, 1996
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureasP Y Lam, Y Ru, P K Jadhav, et al.
Cancer|April 20, 2026
Phase 2 trial of exercise and low-dose ibuprofen for cancer-related cognitive impairment in patients receiving chemotherapyMichelle C Janelsins, Riham A Alieldin, Tyler Holler, et al.
Leukemia|August 30, 2019
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysisStefan Knop, Monika Engelhardt, Peter Liebisch, et al.
Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.
Transplantation and Cellular Therapy|March 28, 2024
A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHDMuna Qayed, Urvi Kapoor, Scott Gillespie, et al.
Pageof 149